|
COMACC HOME > Training Programs > The University of Texas Southwestern Medical Center at Dallas
The University of Texas Southwestern Medical Center at Dallas
| Director: |
Address: |
| Frank H. Wians, Jr., Ph.D., DABCC,
FACB
Telephone: 214-648-7634/2038
Fax: 214-648-8037
E-mail: Frank.Wians@UTSouthwestern.edu |
Department of Pathology
UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, TX 75390-9073
|
Faculty and Research Interests
| University of Washington
Medical Center |
| Ibrahim I. Hashim, PhD, DABCC, FACB |
Clinical chemistry; immunochemistry |
| Susan Hilton, MD, FACP |
Clinical chemistry; anatomic pathology |
| Patricia M. Jones, PhD, DABCC, FACB |
Pediatric clinical chemistry |
| Martin H. Kroll, MD, FACP, FACB |
Clinical chemistry; anatomic pathology |
| Paul J. Orsulak, PhD, FACB |
Toxicology; trace metal
analysis; therapeutic drug monitoring |
| Elizabeth L. Todd, PhD |
Forensic pathology |
| Frank H. Wians, Jr., PhD, DABCC, FACB |
Clinical chemistry; tumor markers |
| Jiaxi Wu, PhD, MD, DABCC |
Clinical chemistry; molecular pathology |
Program Listing:
| Level(s) of training:
Number of positions available per year:
Duration of program:
Approximate annual salary or stipend:
Source of funding:
Current number of trainees:
Number of past graduates:
Date of ComACC accreditation:
|
Post-doctoral
1
1 year with option for additional year
$40,072
Departmental/Research Grant
2
1
1 Dec 04
|
Application Procedures:
| Prerequisites: |
PhD in biological sciences or MD; adequate education
in biological chemistry at the graduate level. MD candidate must obtain
a Texas Institutional Permit. |
| Procedures: |
Follow instructions and complete application at website: http://pathcuric1.swmed.edu/Teaching/fellowship/clinical_fellow.htm
Only applicants who complete the on-line application process, including
sub-mission of all necessary supporting documents, will be competitively
considered for selection (i.e., do NOT send C.V. only directly to
Program Director). On-site interview, at candidate’s expense,
required.
|
| Deadline: |
31 December of the year preceding the 1 Jul start date
of the CCF Program |
|
Program Description
The University of Texas Southwestern Medical Center
(UTSWMC) at Dallas consists of 3 large or medium-size full service
hospitals, a children’s hospital, an ambulatory care facility,
and a veteran’s hospital: Parkland Health & Hospital Systems,
St. Paul and Zale Lipshy University Hospitals, Aston Ambulatory
Care Center, Children’s Medical Center, and the Veteran’s
Administration Medical Center.
The Clinical Chemistry Fellowship (CCF) Program at UTSWMC provides
trainees with the basic skills required for the practice of clinical
chemistry in an academic or community hospital or indus-trial setting
and to successfully complete the board examination in clinical chemistry
administered by the American Board of Clinical Chemistry (ABCC)
or the American College of Pathology (ACP). Mechanisms for achieving
these goals include: mentoring by members of the clinical chemistry
faculty; participation in a research project under the direction
of his/her Clinical Chemis-try Research and Faculty Advisor; coordinating
with a faculty member and overseeing pathology residents providing
direct assistance to Interventional Radiologists in the surgical
suite on patients undergoing bilateral inferior petrosal sinus sampling
(IPSS), adrenal vein sampling (AVS), or selec-tive sampling for
parathormone (PTH); participation in, at the discretion of the trainee’s
Research and Faculty Advisor on an as needed basis, other special
projects/tasks, not defined herein, with di-rect teaching value
and benefit to the trainee.
In addition, attendance by the CCF is required at a variety of
symposia with extensive learning benefit and value, including weekly
Internal Medicine Grand Rounds, a forum for members of the Department
of Internal Medicine at UTSWMC to present a mini-review of a clinical
medicine topic related to their area of expertise and specialization;
monthly Clinical Chemistry Grand Rounds Lec-ture Series,
a forum for presentations by well known outside speakers on topics
directly related to clinical chemistry; annual Laboratory
Management Course for Pathology Residents; annual review
of the Pathology Resident In-Service Examination (RISE); annual
Progress in Clinical Pathology Course; and, funding permitting,
the annual meeting of the American Association for Clinical
Chemistry (AACC) and at local meetings of other professional and
scientific organizations [e.g., Texas Section, AACC, Clinical Ligand
Assay Society (CLAS)].
Prior to completion of the Fellowship program, the Fellow will
be required to attain a satisfactory score on a Comprehensive Examination.
Upon completion of the CCF, fellows should be familiar with the
principal indication for clinician ordering, the principle, and
interpretation of a wide variety of clinical chemistry tests and
proce-dures; be able to assist clinicians in the appropriate use
and interpretation of clinical laboratory tests for a wide variety
of diseases; know the rationale, procedure, and interpretation of
results for the inferior petrosal sinus sampling, adrenal vein sampling,
and selective sampling for PTH procedures; be familiar with the
requirements of the Clinical Laboratory Improvement Amendments of
1988 (CLIA ’88) as they pertain to clinical chemistry laboratories;
know the principles and methods used for evaluating and validating
the analytical and clinical performance characteristics of clinical
chemistry tests, including basic statistical techniques; be familiar
with modern concepts of effective management, administrative, and
leadership strategies; and, understand the principles and methods
for establishing a clinical chemistry quality control/quality assurance
(QC/QA) program.
|
|